<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">ORPHENADRINE CITRATE</span><br/>(or-fen'a-dreen)<br/><span class="topboxtradename">Banflex, </span><span class="topboxtradename">Flexon, </span><span class="topboxtradename">Myolin, </span><span class="topboxtradename">Norflex<br/></span><b>Classifications:</b> <span class="classification">somatic nervous system agent</span>; <span class="classification">skeletal muscle relaxant</span>; <span class="classification">central-acting</span><br/><b>Prototype: </b>Cyclobenzaprine<br/><b>Pregnancy Category: </b>C<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>100 mg tablets; 100 mg sustained-release tablets; 30 mg/mL injection</p>
<h1><a name="action">Actions</a></h1>
<p>Tertiary amine anticholinergic agent and central-acting skeletal muscle relaxant.</p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Relaxes tense skeletal muscles indirectly, possibly by analgesic action or by atropinelike central action. Has some local
         anesthetic and antihistaminic activity but less than that of diphenhydramine. Also produces slight euphoria.
      </p>
<h1><a name="uses">Uses</a></h1>
<p>To relieve muscle spasm discomfort associated with acute musculoskeletal conditions.</p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Narrow-angle glaucoma; pyloric or duodenal obstruction, stenosing peptic ulcers; prostatic hypertrophy or bladder neck obstruction;
         myasthenia gravis; cardiospasm (megaloesophagus). Safe use during pregnancy (category C), lactation, or in the pediatric age
         group is not established.
      </p>
<h1><a name="precaution">Cautious Use</a></h1>
<p>History of tachycardia, cardiac decompensation, arrhythmias, coronary insufficiency.</p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Muscle Spasm</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 100 mg b.i.d. <span class="rdroute">IM/IV</span> 60 mg, may repeat in 12 h if needed<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Oral</span><br/><ul>
<li>Ensure that sustained-release form is not chewed or crushed. It must be swallowed whole.</li>
</ul>
<table cellpadding="4" cellspacing="0" class="ivbox" width="100%">
<tr>
<td><span class="ivtitle">Intravenous</span><p><span class="routemethod">PREPARE:</span> <span class="methodtype">Direct:</span> Give undiluted. Protect from light.  
               </p>
<p><span class="routemethod">ADMINISTER:</span> <span class="methodtype">Direct:</span> Give at a rate of 60 mg (2 mL) over 5 min.  
               </p>
</td>
</tr>
</table>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">CNS:</span> <span class="speceff-common">Drowsiness,</span> weakness, headache, dizziness; mild CNS stimulation (high doses: restlessness, anxiety, tremors, confusion, hallucinations,
      agitation, tachycardia, palpitation, syncope). <span class="typehead">Special Senses:</span> Increased ocular tension, dilated pupils, blurred vision. <span class="typehead">GI:</span> <span class="speceff-common">Dry mouth,</span> nausea, vomiting, abdominal cramps, constipation. <span class="typehead"> Urogenital:</span> <i>Urinary hesitancy</i> or <i>retention</i>. <span class="typehead">Body as a Whole:</span> Hypersensitivity [pruritus, urticaria, rash, <span class="speceff-life">anaphylactic reaction</span> (rare)]. 
      <h1><a name="interactions">Interactions</a></h1><span class="typehead">Drug:</span> <b>Propoxyphene</b> may cause increased confusion, anxiety, and tremors; may worsen schizophrenic symptoms, or increase risk of tardive dyskinesia
      with <b>haloperidol;</b> additive CNS depressant with <span class="classification">anxiolytics</span>, <span class="classification">sedatives</span>, <span class="classification">hypnotics</span>, <b>butorphanol,</b> <b>nalbuphine,</b> <span class="classification">opiate agonists</span>, <b>pentazocine,</b> <b>tramadol.</b> <span class="typehead">Herbal:</span> <b>Valerian,</b> <b>kava kava</b> potentiate sedation. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> Readily absorbed from GI tract. <span class="typehead">Peak:</span> 2 h. <span class="typehead">Duration:</span> 46 h. <span class="typehead">Distribution:</span> Rapidly distributed in tissues; crosses placenta. <span class="typehead">Metabolism:</span> Metabolized in liver. <span class="typehead">Elimination:</span> Excreted in urine. <span class="typehead">Half-Life:</span> 14 h. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Lab tests: Periodic blood, urine, and liver function studies with prolonged therapy.</li>
<li>Report complaints of mouth dryness, urinary hesitancy or retention, headache, tremors, GI problems, palpitation, or rapid
            pulse to physician. Dosage reduction or drug withdrawal is indicated.
         </li>
<li>Monitor elimination patterns. Older adults are particularly sensitive to anticholinergic effects (urinary hesitancy, constipation);
            closely observe.
         </li>
<li>Monitor therapeutic drug effect. In the patient with parkinsonism, orphenadrine reduces muscular rigidity but has little effect
            on tremors. Some reduction in excessive salivation and perspiration may occur, and patient may appear mildly euphoric.
         </li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Relieve mouth dryness by frequent rinsing with clear tepid water, increasing noncaloric fluid intake, sugarless gum, or lemon
            drops. If these measures fail, a saliva substitute may help.
         </li>
<li>Do not drive or engage in potentially hazardous activities until response to drug is known.</li>
<li>Avoid concomitant use of alcohol and other CNS depressants; these may potentiate depressant effects.</li>
<li>Do not breast feed while taking this drug without consulting physician.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>